Promjene intenziteta boli i kvalitete života povezane s oralnim zdravljem u pacijenata s temporomandibularnim poremećajima tijekom terapije stabilizacijskom udlagom – probno ispitivanje by Alajbeg Iva Z. et al.
Acta Clin Croat,  Vol. 53,   No. 1,  2014 7
Acta Clin Croat 2014; 53:7-16 Original Scientific Paper
ChAngeS in PAin intenSity And OrAl heAlth-
relAted quAlity Of life in PAtientS with 
temPOrOmAndibulAr diSOrderS during 
StAbilizAtiOn SPlint therAPy – A PilOt Study
iva z. Alajbeg1, marijana gikić2 and melita Valentić-Peruzović3
1department of Prosthodontics, School of dental medicine, university of zagreb; 2Private dental Practice; 
3department of Prosthodontics, zagreb university hospital Center, zagreb, Croatia 
SummAry – The aim of the study was to evaluate changes in pain intensity and self-perceived 
quality of life in patients with temporomandibular disorders (tmd) during stabilization splint 
therapy. The hypothesis was that the clinical subtype of tmd, depending on whether pain is of 
muscular or temporomandibular joint origin, and pain chronicity (acute vs. chronic pain) differently 
affect treatment response. Thirty patients were included and treated with a stabilization splint in 
a 6-month clinical trial. treatment outcomes included pain-free maximal mouth opening (mO), 
assisted maximal mO, path of mO, asymmetry in lateral excursions, spontaneous pain intensity 
(visual analog scale, VAS), and self-perceived quality of life (Oral health impact Profile, OhiP-
14). Overall, VAS and OhiP-14 scores changed significantly over time (VAS: f=80.85, p<0.001; 
OhiP-14: f=34.78, p<0.001). After 6 months, changes in pain intensity did not differ significantly 
between myofascial pain (mP) and disc displacement (dd) groups (f=0.497, p=0.685, effect size 
= 0.018), or between acute pain (AP) and chronic pain (CP) patients (f=1.856, p=0.144, effect size 
= 0.064). Changes in self-perceived quality of life did not differ significantly between mP and dd 
groups (f=0.213, p=0.847, effect size = 0.008), or between AP and CP patients (f=0.816, p=0.489, 
effect size = 0.029). linear regression analysis was used to assess the contribution of each predictor 
variable to the explanation of the OhiP summary score variance. results showed pain reduction 
(coefficient = 0.303; 95% Ci: 0.120 to 0.485) and mO increase (coefficient = 0.149; 95% Ci: 0.037 
to 0.260) to be independent predictors of the OhiP-14 summary score changes (r2=0.453), whereas 
other variables did not affect treatment outcome as assessed by OhiP-14. in conclusion, during 
6-month stabilization splint therapy, significant changes in VAS and OhiP-14 summary scores 
were found. however, there were no significant differences in improvement rates between subjects 
with acute and chronic pain. furthermore, no significant differences in improvement rates were 
found depending on whether pain was of muscular or temporomandibular joint origin. 
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Introduction
temporomandibular disorders (tmd) is a collec-
tive term that involves several clinical problems af-
fecting the masticatory muscles, temporomandibular 
joints (tmJ) and associated structures. The research 
diagnostic criteria for tmd (rdC/tmd) provide 
a dual diagnosis that recognizes physical symptoms 
(Axis i) and psychosocial factors (Axis ii). The Axis i 
includes sub-classifications of clinical diagnosis such 
as muscle disorders (myofascial pain) and tmJ dis-
orders (disc dislocations and degenerative joint disor-
ders). There is evidence that no single etiologic factor 
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or a sole etiopathogenetic theory might be responsible 
for tmd as a whole1. The current perspective regard-
ing tmd is multidimensional and many physical, 
social and psychological factors can contribute to the 
development of this disorder2,3. tmd are frequently 
associated with chronic pain and thus have great in-
fluence on social behavior and psychological status of 
patients, and greatly limit the functioning of patients. 
due to considerable psychosocial impact of orofacial 
pain, these patients represent a target population for 
quality of life assessments.
Splint therapy is the most common form of tmd 
treatment4,5. most studies of splint therapy, however, 
have been limited by short duration outcome, small 
sample size, and failure to compare splint therapy 
with other forms of treatment6. in systematic reviews 
including randomized controlled trials (rCt), con-
flicting conclusions were reached on the efficacy of 
occlusal appliance therapy7, but türp et al.8 conclude 
that, based on the currently best available evidence, 
most patients with masticatory muscle pain will be 
helped by the use of a stabilization splint.
The precise mechanism of action of occlusal de-
vices is inconclusive. The historical hypothesis that 
structural deviations from normality are the main 
source for the development of pain has been rejected9. 
Therefore, several other factors potentially influenced 
by stabilization appliance therapy have been suggest-
ed, for example, increased vertical dimension, cogni-
tive awareness, or an increase of peripheral input to 
the central nervous system10. dao and lavigne11 drew 
the conclusion that “the results of controlled clinical 
trials lend support to the effectiveness of the stabi-
lization appliance in the control of myofascial pain”. 
results of recent studies suggest that the splint acts 
primarily as a behavioral intervention, not as a medi-
cal device that changes the position of the jaw.
in many cases, the perception and feelings of pa-
tients regarding their oral health are ignored. when 
dealing with patients who suffer from orofacial pain, 
especially chronic orofacial pain, the impact of pain 
on the quality of life of these individuals should be as-
sessed, but the benefit of treatment in terms of overall 
quality of life improvement must also be considered4,12. 
Some investigators, using subjective indicators of gen-
eral13,14 and oral health15-17, have demonstrated that 
tmd may have great impact on the quality of life. 
however, changes in the self-perceived quality of life 
during stabilization splint therapy in tmd patients 
have not been fully explored. 
The aim of the study was to evaluate changes in the 
self-perceived quality of life and pain intensity in pa-
tients with tmd during stabilization splint therapy. 
The hypothesis was that the clinical subtype of tmd, 
depending on whether pain is of muscular or joint ori-
gin, and pain chronicity (acute vs. chronic pain) differ-
ently affect treatment response measured by changes 
in the Oral health impact Profile (OhiP)-14.
Materials and Methods
The study was conducted at the department of 
Prosthodontics, School of dental medicine, univer-
sity of zagreb. Subjects were selected from patients 
referred to the department of Prosthodontics for re-
ported pain and dysfunction of the temporomandibu-
lar region as the primary problem and had not been 
undergoing any treatment protocols previously. The 
sample included thirty symptomatic tmd patients, 
23 females and 7 males, mean age 36.9 (range 19-63) 
years. to be included in this clinical trial, participants 
had to report having spontaneous pain greater than 
30 millimeters on the visual analog scale (VAS). The 
subjects were informed about the study procedure and 
an informed consent was obtained. The study protocol 
was approved by the ethics Committee of the School 
of dental medicine. exclusion criteria included sub-
jects with: 1) severe periodontitis, 2) removable pros-
thesis, 3) complete fixed prosthodontic restorations, 4) 
psychiatric or neurological disturbances, 5) ongoing 
orthodontic treatment, 6) conditions that may lead to 
degeneration of the joint and arthritis (rdC/tmd 
diagnostic category iii), 7) history of trauma, 8) other 
orofacial pain conditions, and 9) any use of occlusal 
splint in the preceding year.
History data
data on the participants’ age, gender and marital 
status were obtained by a brief structured questionnaire. 
Subjects also filled in data related to the characteristics 
and duration of pain: acute pain (<6 weeks) or chronic 
pain (>6 months). for bruxism, an individual bruxism 
index was created based on clinical examination18,19 and 
reported bruxism (data on whether the subject did, or 
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had in the past, clench or grind their teeth). The indi-
vidual bruxism index (ib) was calculated as the mean 
of two factors involved, as described previously20.
The patients underwent a routine clinical exami-
nation to detect signs and symptoms of tmd. The 
examination was based upon the Croatian version of 
rdC/tmd (Axis i)20,21. The first examiner (i.A.), 
trained in tmd diagnosis, performed clinical and 
functional examination of each patient. According to 
rdC/tmd, subjects were classified into two clini-
cal subtypes: myofascial pain (mP) group (46.7%) and 
disc displacement (dd) group (53.3%). 
Clinical sign evaluation
The second examiner (m.g), who was blind to 
the rdC/tmd and results from the questionnaire, 
performed baseline assessment and reassessment at six 
months after treatment initiation.
Training and calibration of the examiner
Standardization of the examiner and calibration of 
clinical examination was made on ten randomly se-
lected subjects, different from the ones included in the 
investigation. There were no significant differences 
between the first and second measurement (p=0.86-
0.89, paired t-test). 
Pain
Spontaneous pain was evaluated by using a 100 
mm-long VAS. The left endpoint of the scale indi-
cated no pain at all, and the right endpoint indicated 
the worst pain imaginable.
Pain free maximal mouth opening and path of mouth 
opening
maximal ‘pain free’ opening was measured as the 
distance between the maxillary and mandibular in-
cisal edges. The ‘pain free’ opening was defined as the 
maximum distance the participant could open his/her 
mouth without experiencing any additional pain and 
discomfort. The presence of corrected or uncorrected 
deviation during mouth opening was evaluated. 
Assisted maximal mouth opening
The extent of maximal assisted opening was re-
corded. maximal mouth opening was defined as the 
maximum distance the participant could open the 
mouth, even if he/she felt pain or discomfort. After 
the subject had opened this wide, the examiner placed 
his fingers on the participant’s maxillary and man-
dibular central incisors, and forced the participant’s 
mouth open wider. 
The range of mandibular lateral movements
The subject was asked to move the mandible as far 
as possible to the left/right side. The distance from the 
labioincisal embrasure between the maxillary centrals 
to the labioincisal embrasure of the mandibular inci-
sors was measured with a millimeter ruler. 
Complete clinical examination was performed at 
the beginning of the study and at follow-up appoint-
ment (at 6 months of occlusal splint therapy).
Oral health-related quality of life measurement
The oral health-related quality of life (Ohrqol) 
was measured by the 14-item version of the Croatian 
OhiP-1422, which characterizes seven domains (func-
tional limitation, physical pain, psychological discom-
fort, physical disability, psychological disability, social 
disability and handicap) through the use of two items 
for each domain. Subjects were asked how frequently 
they had experienced the impact of that item using a 
likert-type scale (0 – never, 1 – hardly ever, 2 – occa-
sionally, 3 – fairly often, 4 – very often) with zero indi-
cating absence of problems and higher scores indicat-
ing worse oral health. Summary OhiP-14 scores can 
range from 0 to 56. A higher OhiP-14 score indicates 
poorer Ohrqol. The potential validity of the OhiP 
for evaluation of patients with tmd and its previ-
ous utilization for this purpose23,24contributed to the 
adoption in the present study of a version previously 
validated in Croatia22. internal consistency showed 
high Cronbach alpha (0.77-0.91) and test-retest reli-
ability showed high intra-class correlation (correlation 
coefficients, 0.79-0.94).
Stabilization splint fabrication
maxillary stabilization occlusal splint was fabri-
cated on stone cast mounted on SAm-3 articulator 
in centric relation according to centric relation reg-
istration25. it was a hard acrylic (resilit-S, erkodent) 
stabilization type of splint with full coverage of the 
occlusal surfaces. it had a thickness of about 1.5 mm 
at the level of the first molar. The same dental techni-
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cian made all splints. The splint was adjusted to cre-
ate uniform point contact of the centric cusps against 
the splint on all posterior teeth. Anterior teeth were 
in light point contact or were discluded slightly. The 
splint also had canine guidance. Patients were in-
structed to wear the splint only during sleep. Com-
fort, patient acceptance and function of the appliance 
were checked within 2 weeks and the same procedure 
was repeated at all follow-up appointments by the 
same clinician. Patients who felt discomfort associ-
ated with the use of splint, reported using the splint 
not every night, or received additional therapy during 
the follow-up were not included in the study.
Collection of data
Assessments of VAS (distance in millimeters from 
the lower anchor) and OhiP-14 were conducted at 
baseline before occlusal splint therapy (t0), and at 
follow-up appointments at 1 month (t1), 3 months 
(t2) and 6 months (t3) of occlusal splint therapy. 
immediately after the questionnaires had been com-
pleted by the patient, the forms were sealed in a coded 
envelope by the clinician.
Statistical analysis
The SPSS (version 17) statistical package was 
used in all analyses. The pretreatment and 6-month 
follow-up data were analyzed by chi-square analy-
sis and t-test. univariate analysis of variance for re-
peated measurements was used to test the assessment 
(baseline-t0, t1, t2 and t3) differences in VAS and 
OhiP-14 scores. Statistical significance was assessed 
at the 0.05 level and then adjusted for multiple com-
parisons by the bonferroni method. linear regression 
Table 1. Sample characterization
disc displacement (n=16) myofascial pain (n=14)























time from pain onset: 
<6 weeks (acute)
>6 months (chronic)
  6 (37.5)
10 (62.5)
















37.59 (10.25) 22-54 9 (64.3)
5 (35.7)
33.46 (8.48) 20.5-49
maximal assisted mouth 
opening (mm) 45.40 (9.14) 30-62 40.96 (10.10) 22.5-58
VAS at baseline (mm) 64.75 (12.06) 40-85 70.28 (11.54) 50-86
OhiP-14 26.94 (8.86) 14-43 25.29 (12.38) 7-48
VAS = pain (mm) on visual analog scale;
OhiP-14 = Oral health impact Profile summary score.
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analysis was used to assess the contribution of each 
predictor variable (pain reduction, increase in mouth 
opening, path of opening improvement, symmetry in 
lateral excursions) to the explanation of the variance of 
the OhiP summary score changes (t0-t3) in tmd 
patients wearing occlusal stabilization splint. Socio-
demographic variables (age and gender), the presence 
of bruxism, pain duration and clinical subgroup were 
included as control variables.
Results
The sample characterization is given in table 1. 
The mean age of 30 study participants was 36.9 (range 
19-63) years. Patients were classified according to 
clinical diagnoses of the rdC/tmd Axis i. four-
teen (46.7%) patients met the criteria for myofascial 
pain (mP) and 16 patients (53.3%) met the criteria 
for disc displacement (dd). forty-three percent of all 
patients reported pain with a duration of 6 months or 
more; 57% of patients had pain for less than 6 weeks. 
The mean value for the worst pain at baseline was 67.33 
(range 40-86) for all patients. bruxism was present in 
56.7% of all patients. up to 6 months of appliance 
therapy, none of the 30 patients demanded additional 
treatment. There were no statistically significant dif-
ferences between the mP and dd groups according to 
age (t=-0.935; p=0.358), gender (χ2=0.053; p=0.818), 
duration of pain (t=1.284; p=0.210), intensity of pain 
on VAS (t0) at baseline (t=-1.279; p=0.211), bruxism 
(χ2=2.330; p=0.127) and range of opening: ‘pain free’ 
(t=-1.191; p=0.244) and maximal assisted (t=1.264; 
p=0.217) .
The pretreatment and 6-month follow-up data were 
analyzed by chi-square (path of opening and asym-
metry in lateral excursions) and t-test for dependent 
samples (range of ‘pain free’ mouth opening, range of 
assisted mouth opening). deviations in mouth open-
ing were observed in 13 (81%) patients in dd group 
and 10 (71%) patients in mP group at baseline. The 
path of mouth opening improved within both groups 
at 6-month follow-up (table 2) (dd group p=0.001; 
mP group p=0.002). Asymmetry in lateral excursions 
improved significantly in mP group at 6-month fol-
low-up (14% still presented asymmetry, p=0.018). The 
range of mandibular opening improved significantly 
after 6 months of treatment (p<0.05) in both groups 
(table 3).
Table 2. Frequencies (percentage distribution) of some clinical findings in myofascial pain (MP) and disc displacement 
(DD) groups at baseline and at 6-month follow up
baseline (t0) 6-month follow up (t3) χ
2 p























































Statistical evaluation by χ2; n = number of subjects; t0 = baseline; t3 = follow up appointment at 6 months of occlusal splint therapy; *clinical 
evidence of asymmetry in the presence of >2 mm difference in right and left laterotrusion.
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Change in VAS and OHIP-14 
for pain intensity, VAS scores improved signifi-
cantly over time (f=80.85, p<0.001, effect size=0.750). 
After 6 months, changes in pain intensity did not 
differ significantly between the mP and dd groups 
(f=0.497, p=0.685, effect size=0.018) (fig. 1) or be-
tween acute pain (AP) and chronic pain (CP) patients 
(f=1.856, p=0.144, effect size=0.064) (fig. 2).
general improvement in the quality of during the 
study period was clearly shown by the gradual decrease 
of all mean OhiP-14 summary scores (f=34.78, 
p<0.001, effect size=0.564). After 6 months, changes 
in the self-perceived quality of life did not differ sig-
nificantly between the mP and dd groups (f=0.213, 
p=0.847, effect size=0.008) (fig. 3) or between AP 
and CP patients (f=0.816, p=0.489, effect size=0.029) 
(fig. 4).
Fig. 1. Visual analog scale (VAS) pain intensity in 
myofascial pain (MP) and disc displacement (DD) 
groups at various time intervals: T0 – baseline, 
T1 – 1-month-, T2 – 3-month- and T3 – 6-month 
follow up of occlusal splint therapy.
Fig. 2. Visual analog scale (VAS) pain intensity in acute 
and chronic pain patients at various time intervals: 
T0 – baseline, T1 – 1-month-, T2 – 3-month- and T3 – 
6-month follow up of occlusal splint therapy. 
Table 3. Comparison of different variables measured in myofascial pain and disc displacement groups at various time 
intervals
baseline (t0) 6-month follow up (t3) t p
group mean (Sd) min-max mean (Sd) min-max
disc 
displacement
'Pain free' mouth 
opening (mm) 37.59 (10.26) 22-54 44.78 (7.27) 34-59 -4.46 <0.001
myofascial 
pain
'Pain free' mouth 








mouth opening (mm) 40.96 (10.1) 22.5-58 49.32 (5.7) 38-59 -3.31 0.006
rOm = range of mouth opening; statistical evaluation by paired t-test; t0=baseline; 
t3= follow-up appointment at 6months of occlusal splint therapy.
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linear regression analysis was performed to iden-
tify the best independent variables (pain reduction, 
increase of mouth opening, path of opening improve-
ment, symmetry in lateral excursions) for predicting the 
impact estimated by the quality of life (dependent vari-
able). The construction of the model took confound-
ing variables and colinearity into account. The variables 
that explained linear variation of the OhiP-14 sum-
mary score were identified through a forward stepwise 
process. The variables identified as the best predictive 
variables for good quality of life (analyzing the OhiP 
score: t0-t3 change) were VAS reduction (coefficient 
= 0.303; 95% Ci: 0.120 to 0.485) and increase of mouth 
opening (coefficient = 0.149; 95% Ci: 0.037 to 0.260). 
The model explained 45% (r2=0.453) of the impact on 
the patient quality of life. Other variables did not affect 
treatment outcome as assessed by OhiP. 
Discussion
This preliminary study was designed to evaluate 
changes in the self-perceived quality of life and pain 
intensity in patients with tmP during stabilization 
splint therapy. This can help upgrade the understand-
ing of the effects of this type of therapy on the patients’ 
lives. it should be borne in mind that spontaneous re-
mission is an important factor for positive outcome. 
however, we tried to minimize the impact of this fac-
tor on the result by introducing subjects with different 
pain duration (chronic pain vs. acute pain) in order to 
see if the pain duration variable had a significant im-
pact on treatment outcome. in other words, the study 
included a group of patients with orofacial pain who 
were untreated for 6 months. it is likely that the splint 
acted curatively, as in these patients spontaneous im-
provement had failed to occur over a long period be-
fore splint therapy; however, no direct evidence for 
this exists due to the lack of control group.
in the present study, the beneficial use of stabi-
lization occlusal splint was observed in both clini-
cal subtypes of tmd. A reduction of tmd signs/
symptoms was noted. in the present study, 13 of 16 
patients in dd group and 10 of 14 patients in mP 
group presented deviations during mouth opening at 
the time of diagnosis. Jaw function was improved in 
both groups; only four (25%) patients in dd group 
and two (14.3%) patients in mP group still presented 
deviations on mouth opening at 6-month follow up. 
eight patients in mP group had asymmetry dur-
ing lateral excursions at the time of diagnosis and it 
persisted in only two patients at 6-month follow up. 
Other authors26 also report improvement in mouth 
opening after splint therapy.
Fig. 3. Oral Health Impact Profile (OHIP)-14 score 
in myofascial pain (MP) and disc displacement (DD) 
groups at various time intervals: T0 – baseline, 
T1 – 1-month-, T2 – 3-month- and T3 – 6-month 
follow up of occlusal splint therapy.
Fig. 4. Oral Health Impact Profile (OHIP)-14 score in 
acute and chronic pain patients at various time intervals: 
T0 – baseline, T1 – 1-month-, T2 – 3-month- and 
T3 – 6-month follow up of occlusal splint therapy.
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findings from double-blind, controlled, short-
term studies in patients with tmd of arthrogenous 
origin suggest that the use of stabilization splints for 
the treatment of tmJ pain may be beneficial for re-
ducing pain severity, at rest and on palpation, when 
compared with a control appliance27,28. Still, well-de-
signed randomized clinical trials with long-term eval-
uation are lacking, and there is not enough evidence 
from trials to show whether or not stabilization splint 
may reduce pain in painful tmd7.
Previous studies have suggested that with longer 
pain duration, the condition becomes more refractory 
to traditional medical treatment approaches29. in the 
study by emshoff30, the time from pain onset con-
tributed significantly to these changes. in our group 
of patients, however, patients suffering from chronic 
pain showed similar improvement in VAS and OhiP 
scores as subjects suffering from acute pain.
most of our patients reported that their condition 
improved during the trial and VAS data showed that 
reduction in the intensity of pain was progressive. At 
6-month follow up, pain reduction by >70% was re-
corded in 44% of patients in dd group and in 78% of 
patients in mP group. This observation compares fa-
vorably with the results of other authors reporting on 
the frequencies of total pain remission in tmJ pain 
and dysfunction ranging from 30% to 70%30,31. 
in our study group as a whole, the quality of life 
improved with time, i.e. from pretreatment assess-
ment through the 1-month and 3-month to 6-month 
follow-up appointments. The mean pretreatment 
OhiP-14 score (dd=26.94; mP=25.29) recorded in 
this study was higher than the means reported by bar-
ros et al.24 and luo et al.32, reflecting a stronger effect 
on the quality of life in our sample. it would be useful, 
however, to compare changes in the quality of life be-
tween the treated group and control group; however, 
assessment in an untreated control group during six-
month follow up raises a number of ethical dilemmas. 
furthermore, study patients may represent a group of 
more severe cases with a more severe quality of life 
impairment, and their outcomes cannot apply to the 
entire population. taking the limitations of this study 
into account, the results still show a significant impact 
of orofacial pain on the patient quality of life.
Our results showed that the best predictive vari-
ables for good quality of life were VAS reduction and 
increase of mouth opening. it is known that pain has 
considerable impact on the quality of life33. in our 
study, however, quality of life improvement occurred 
both in acute and in chronic pain patients. This im-
provement could occur spontaneously or due to the 
possible placebo effect, but the fact remains that 
chronic pain patients were there for a longer period 
than the splint treatment lasted. in this subgroup, 
there was sufficient time for spontaneous healing, 
should this be the case. Thus, we could ascribe symp-
tom improvement to the effect of treatment rather 
than to spontaneous remission. This pilot study en-
courages further studies that should include an ac-
tive control group in order to evaluate the extent of 
the possible placebo effect.
Conclusions
within the limitations of this study, significant 
changes in the VAS and OhiP-14 summary scores 
were found between baseline and follow up appoint-
ments while on occlusal splint therapy. This pilot 
study provided preliminary evidence that there were 
no significant differences in improvement rates be-
tween subjects with acute and chronic pain. further-
more, no significant differences in improvement rates 
were found depending on whether pain was of mus-
cular or tmJ origin. The variables identified as the 
best predictive variables for good quality of life were 
reduction of pain and increase of mouth opening.
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Sažetak
PrOmJene intenzitetA bOli i KVAlitete ŽiVOtA POVezAne S OrAlnim zdrAVlJem 
u PACiJenAtA S temPOrOmAndibulArnim POremećAJimA tiJeKOm terAPiJe 
StAbilizACiJSKOm udlAgOm – PrObnO iSPitiVAnJe
I. Z. Alajbeg, M. Gikić i M. Valentić-Peruzović
Cilj istraživanja bio je ispitati promjene intenziteta boli i kvalitete života u bolesnika s temporomandibularnim poreme-
ćajima (tmP) tijekom terapije stabilizacijskom udlagom. u istraživanju se vodilo hipotezom da klinički podtip tmP-a, 
ovisno o tome je li bol mišićnog ili zglobnog podrijetla, i kronicitet (akutna ili kronična bol) različito odgovaraju na liječe-
nje. u istraživanje je uključeno tridesetoro pacijenata koji su tijekom šestomjesečnog kliničkog ispitivanja liječeni stabili-
zacijskom udlagom. mjere ishoda uključivale su maksimalno otvaranje usta bez boli, asistirano maksimalno otvaranje usta 
(pasivno rastezanje), postojanje devijacije/defleksije pri otvaranju, asimetriju pri lateralnim kretnjama, bol prema vizualno 
analognoj skali (VAS) te samoprocjenu kvalitete života i njenu povezanost s oralnim problemima (upitnik OhiP-14). 
tijekom šestomjesečnog liječenja udlagom iznos boli prema VAS te zbroj bodova upitnika OhiP-14 značajno su sniženi 
(VAS: f=80,85; p<0,001; OhiP-14: f=34,78; p<0,001 ). između pacijenata s mišićnim (mP) ili zglobnim poremećajima 
(dd) nisu pronađene značajne razlike u promjeni intenziteta boli nakon liječenja (f=0,497; p=0,685, veličina učinka = 
0,018). isto tako, nisu pronađene značajne razlike ni između pacijenata s akutnom (AP) ili kroničnom boli (CP) (f=1,856; 
p=0,144, veličina učinka = 0,064). Promjena u percepciji kvalitete života nije se bitno razlikovala između skupina mP i dd 
(f=0,213; p=0,847, veličina učinka = 0,008), kao ni između skupina AP i CP (f=0,816; p=0,489, veličina učinka = 0,029). 
linearna regresija korištena je kako bi se procijenio doprinos svake prediktorske varijable u objašnjenju varijance ukupnog 
zbroja bodova upitnika OhiP-14. rezultati su pokazali da su smanjenje boli (koeficijent = 0,303; 95% Ci: 0,120-0,485 ) i 
povećanje iznosa maksimalog otvaranja usta (koeficijent = 0,149; 95% Ci: 0,037-0,260 ) varijable najjače povezane s pro-
mjenom zbroja bodova upitnika OhiP-14 tijekom šestomjesečnog liječenja udlagom (r2=0,453), dok ostale varijable nisu 
imale utjecaj na ishod liječenja. u zaključku, tijekom šestomjesečne terapije stabilizacijskom udlagom došlo je do značajnog 
smanjenja boli prema VAS te do poboljšanja kvalitete života (OhiP-14). nije, međutim, bilo značajnih razlika u iznosu 
napretka između ispitanika s akutnom i kroničnom boli. nadalje, nije bilo značajnih razlika u iznosu poboljšanja ovisno o 
tome je li ta bol bila mišićnog ili zglobnog podrijetla.
Ključne riječi: Okluzijska udlaga; Temporomandibularni poremećaji – terapija; Bol, procjena; Kvaliteta života
